Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 0: clinchem.2004.033225v1, 2004; 10.1373/clinchem.2004.033225
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2004.033225v1
50/11/1994    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumur, C. I.
Right arrow Articles by Ferreira-Gonzalez, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumur, C. I.
Right arrow Articles by Ferreira-Gonzalez, A.

Received on February 19, 2004
Accepted on July 29, 2004

Molecular Diagnostics and Genetics

Evaluation of Quality-Control Criteria for Microarray Gene Expression Analysis

Catherine I. Dumur 1, Suhail Nasim 1, Al M. Best 2, Kellie J. Archer 2, Amy C. Ladd 1, Valeria R. Mas 3, David S. Wilkinson 1, Carleton T. Garrett 1, Andrea Ferreira-Gonzalez 1*

1 Department of Pathology, Virginia Commonwealth University, Richmond, VA.
2 Department of Biostatistics, Virginia Commonwealth University, Richmond, VA.
3 Department of Surgery, Virginia Commonwealth University, Richmond, VA.

* To whom correspondence should be addressed. E-mail: agonzalez{at}hsc.vcu.edu.

Background: Development of quality-control criteria to ensure reproducibility of microarray results for potential clinical application is still in its infancy.

Methods: In the present studies we developed quality-control criteria and evaluated their effect in microarray data analysis using total RNA from cell lines, frozen tumors, and a commercially available reference RNA. Quality-control criteria such as A260/A280 ratios, percentage of rRNA, and median size of cDNA and cRNA synthesis products were evaluated for robustness in microarray analysis. Furthermore, precision studies using a reference material were performed on the Affymetrix® HG-U133A high-density oligonucleotide microarrays. The same reference RNA sample was examined in 16 different chips run on 2 different days in the four different modules of the Affymetrix fluidics workstation. Fresh and frozen fragmented cRNAs were also compared. An ANOVA model was fit to identify the main sources of variation.

Results: Good-quality samples showed >30% rRNA in the electropherograms and cDNA and cRNA synthesis products with median sizes of 2.0 and 3.0 kb, respectively. Precision studies showed that the main source of variation was the one introduced by the day-to-day variability, minimally affecting hybridization addition control genes. Altogether, the results showed that the Affymetrix Genechip® system is highly reproducible when RNA that meet the quality-control criteria are used (overall P >0.01).

Conclusions: These results confirm the need to establish defined quality-control criteria for sample quality to distinguish between analytical and biological variability.


The following articles in journals at HighWire Press have cited this article:


Home page
 Brief Funct Genomic ProteomicHome page
X. Ye and R. Lotan
Potential misinterpretation of data on differential gene expression in normal and malignant cells in vitro
Brief Funct Genomic Proteomic, July 1, 2008; 7(4): 322 - 326.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
C. I. Dumur, M. Lyons-Weiler, C. Sciulli, C. T. Garrett, I. Schrijver, T. K. Holley, J. Rodriguez-Paris, J. R. Pollack, J. L. Zehnder, M. Price, et al.
Interlaboratory Performance of a Microarray-Based Gene Expression Test to Determine Tissue of Origin in Poorly Differentiated and Undifferentiated Cancers
J. Mol. Diagn., January 1, 2008; 10(1): 67 - 77.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. S. Winter, Z. Jiang, H. M. Khawaja, T. Griffin, M. Devidas, B. L. Asselin, and R. S. Larson
Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group
Blood, September 1, 2007; 110(5): 1429 - 1438.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
G. Sadri-Vakili, B. Bouzou, C. L. Benn, M.-O. Kim, P. Chawla, R. P. Overland, K. E. Glajch, E. Xia, Z. Qiu, S. M. Hersch, et al.
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models
Hum. Mol. Genet., June 1, 2007; 16(11): 1293 - 1306.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
K. J. Archer and T. Guennel
An application for assessing quality of RNA hybridized to Affymetrix GeneChips
Bioinformatics, November 1, 2006; 22(21): 2699 - 2701.
[Abstract] [Full Text] [PDF]

Home page
 BiostatisticsHome page
K. J. Archer, C. I. Dumur, S. E. Joel, and V. Ramakrishnan
Assessing quality of hybridized RNA in Affymetrix GeneChip experiments using mixed-effects models
Biostat., April 1, 2006; 7(2): 198 - 212.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
T. M. Daly, C. M. Dumaual, C. A. Dotson, M. W. Farmen, S. K. Kadam, and R. D. Hockett
Precision Profiling and Components of Variability Analysis for Affymetrix Microarray Assays Run in a Clinical Context
J. Mol. Diagn., August 1, 2005; 7(3): 404 - 412.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Imbeaud, E. Graudens, V. Boulanger, X. Barlet, P. Zaborski, E. Eveno, O. Mueller, A. Schroeder, and C. Auffray
Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces
Nucleic Acids Res., March 30, 2005; 33(6): e56 - e56.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the American Association for Clinical Chemistry.